Approach to the Patient: Cases of Hormonal Management in Older Transgender and Gender Diverse Adults
Listen to this summary
This article addresses the management of gender-affirming hormone therapy (GAHT) in older transgender and gender diverse (TGD) adults, particularly in the context of age-related health issues such as neurocognitive disorders, cardiovascular disease, prostate cancer, bone health, and menopause. The authors aim to provide a case-based framework for healthcare providers, highlighting the lack of specific evidence-based guidelines for this population and the need for future research to establish best practices.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Journal of clinical endocrinology and metabolism
View all →Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis
Jun 11, 2026 · The Journal of clinical endocrinology and metabolism
The Utility of Salivary 11-Dehydrodexamethasone as a Marker of Dexamethasone Absorption
More in Pediatrics
View all →Aug 7, 2026 · European heart journal
Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies
Aug 7, 2026 · Critical care medicine
Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis
Aug 7, 2026 · Pediatric nephrology (Berlin, Germany)
Anti-rituximab antibodies: implications for clinical outcomes and safety in pediatric idiopathic nephrotic syndrome
Aug 7, 2026 · Critical care medicine
Rethinking Muscle Wasting in Critical Illness: A Systematic Review and Meta-Analysis of Myofiber Size and Protein Turnover
Aug 7, 2026 · Critical care medicine
Telemedicine Critical Care Billing For Hospitalized Medicare Fee-For-Service Beneficiaries, 2018-2024
Aug 7, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


